⌘K

Login Start Free

Home/Filings/4/0001087294-26-000004

4//SEC Filing

KAZIMI A J 4

Accession 0001087294-26-000004

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:03 PM ET

Size

36.6 KB

Accession

0001087294-26-000004

Insider Transaction Report

Form 4

Period: 2025-12-01

CUMBERLAND PHARMACEUTICALS INCCPIX

DirectorChairman and CEO10% Owner

Transactions

Small Acquisition
Common Stock
2025-12-01$2.36/sh+18$42→ 5,700,903 total
Small Acquisition
Common Stock
2025-12-02$2.24/sh+18$40→ 5,700,921 total
Small Acquisition
Common Stock
2025-12-03$2.25/sh+18$41→ 5,700,939 total
Small Acquisition
Common Stock
2025-12-04$2.27/sh+18$41→ 5,700,957 total
Small Acquisition
Common Stock
2025-12-05$2.34/sh+18$42→ 5,700,975 total
Small Acquisition
Common Stock
2025-12-08$2.40/sh+14$34→ 5,700,989 total
Small Acquisition
Common Stock
2025-12-09$2.32/sh+14$32→ 5,701,003 total
Small Acquisition
Common Stock
2025-12-10$2.60/sh+14$36→ 5,701,017 total
Small Acquisition
Common Stock
2025-12-11$2.56/sh+14$36→ 5,701,031 total
Small Acquisition
Common Stock
2025-12-12$2.50/sh+14$35→ 5,701,045 total
Small Acquisition
Common Stock
2025-12-15$2.82/sh+14$39→ 5,701,059 total
Small Acquisition
Common Stock
2025-12-16$3.27/sh+14$46→ 5,701,073 total
Small Acquisition
Common Stock
2025-12-17$3.65/sh+10$37→ 5,701,083 total
Small Acquisition
Common Stock
2025-12-18$4.19/sh+10$42→ 5,701,093 total
Small Acquisition
Common Stock
2025-12-19$4.19/sh+8$34→ 5,701,101 total
Small Acquisition
Common Stock
2025-12-22$4.32/sh+7$30→ 5,701,108 total
Small Acquisition
Common Stock
2025-12-23$4.13/sh+8$33→ 5,701,116 total
Small Acquisition
Common Stock
2025-12-24$4.26/sh+8$34→ 5,701,124 total
Small Acquisition
Common Stock
2025-12-26$4.21/sh+8$34→ 5,701,132 total
Small Acquisition
Common Stock
2025-12-29$4.01/sh+8$32→ 5,701,140 total
Small Acquisition
Common Stock
2025-12-30$3.94/sh+8$32→ 5,701,148 total
Small Acquisition
Common Stock
2025-12-31$3.91/sh+7$27→ 5,701,155 total

Footnotes (1)

[F1]The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.

Documents

1 file

4
wk-form4_1767737028.xmlPrimary
FORM 4

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001075050

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 5:03 PM ET
Size: 36.6 KB

View on SEC.gov